Mary Fisher

Insider Reports History

Entity
Individual
Location
C/O Acorda Therapeutics, Inc., 15 Skyline Drive, Hawthorne, New York
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Fisher:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sientra, Inc. Director Common Stock 19.6K $13.9K $0.71 Jun 15, 2023 Direct
Dermata Therapeutics, Inc. Director Stock Option (Right to Buy) 10K Jan 4, 2024 Direct

Insider Reports Filed by Mary Fisher

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DRMA Dermata Therapeutics, Inc. Jan 4, 2024 1 $0 4 Jan 5, 2024 Director
SIEN Sientra, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
DRMA Dermata Therapeutics, Inc. Oct 6, 2022 1 $0 4 Oct 7, 2022 Director
DRMA Dermata Therapeutics, Inc. Jul 7, 2022 1 $0 4 Jul 8, 2022 Director
SIEN Sientra, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
DRMA Dermata Therapeutics, Inc. Apr 7, 2022 1 $0 4 Apr 8, 2022 Director
DRMA Dermata Therapeutics, Inc. Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
DRMA Dermata Therapeutics, Inc. Aug 17, 2021 1 $0 4 Aug 17, 2021 Director
DRMA Dermata Therapeutics, Inc. Aug 12, 2021 0 $0 3 Aug 12, 2021 Director
SIEN Sientra, Inc. Jun 10, 2021 1 $0 4 Jun 15, 2021 Director